Home › Companies › Roivant Sciences Ltd. › 2025-2026

Roivant Sciences Ltd. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Roivant Sciences Ltd.’s Form 8-K, filed 2025-09-11 (Item 5.07 on EDGAR). Page generated 04 October 2026.

8Reported items
296Asset managers
1,795Fund votes
2025-09-10Meeting date

Proxy season: 2024-2025 2025-2026

Explore Roivant Sciences Ltd. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Roivant Sciences Ltd.

These tallies are Roivant Sciences Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-09-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Roivant Sciences Ltd. — official shareholder meeting results, meeting held 2025-09-10
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Matthew Gline	430,013,727	--	--	154,432,135	44,227,813	Majority: yes
Elect Director: Keith Manchester	412,869,513	--	--	171,576,349	44,227,813	Majority: yes
Elect Director: Melissa Epperly	429,542,705	--	--	154,903,157	44,227,813	Majority: yes
Proposal 4	628,068,956	479,264	125,455	--	--	Majority: yes
Proposal 5	316,651,402	203,244,184	64,550,276	--	44,227,813	Majority: yes

Source: Roivant Sciences Ltd., Form 8-K, filed with the SEC on 2025-09-11 — read the filing on EDGAR.

How asset managers voted at the Roivant Sciences Ltd. 2025-2026 meeting

Each item below shows how the 296 asset managers that disclosed a Roivant Sciences Ltd. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Roivant Sciences Ltd.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To cast a non-binding, advisory vote to approve the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

36% fund support · no official result

FOR 36%AGAINST 63%

The 286 asset managers below cast 36% of the shares they voted on this item FOR (131,898,572 for, 230,235,713 against).

FOR: 131,898,572 (35.9%)AGAINST: 230,235,713 (62.7%)ABSTAIN: 4,942,227 (1.3%)NOT VOTED: 4,971 (0.0%)

Largest asset managers voting on “To cast a non-binding, advisory vote to approve the compensation of our named executive officers.” at Roivant Sciences Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	0	87,148,276	0	Against
Vanguard	5,827	39,266,249	0	Against
Morgan Stanley	36,558,615	7,964	0	For
VIKING GLOBAL INVESTORS LP	30,322,047	0	0	For
BlackRock	1,680,785	28,271,624	0	Against
QVT Financial LP	29,381,635	0	0	For
State Street	7,595	13,000,107	0	Against
GEODE CAPITAL MANAGEMENT, LLC	0	7,443,269	0	Against
Two Seas Capital LP	5,885,523	0	0	For
Charles Schwab	0	5,789,338	0	Against
Capital Group	0	0	4,832,642	Abstain
PERCEPTIVE ADVISORS LLC	3,162,948	0	0	For
Point72	0	3,080,715	0	Against
Dimensional	0	2,991,598	0	Against
Rubric Capital Management LP	2,949,922	0	0	For
T. Rowe Price	0	2,878,191	0	Against
Northern Trust	0	2,768,670	0	Against
Woodline Partners LP	2,508,892	0	0	For
Polar Capital Holdings Plc	0	2,450,000	0	Against
ORBIMED ADVISORS LLC	0	2,278,760	0	Against
Nuveen	2,264,798	0	0	For
TIAA	2,217,673	0	0	For
Sofinnova Investments, Inc.	0	2,084,636	0	Against
Transamerica	2,078,277	0	0	For
Goldman Sachs	2,031,796	0	0	For

Showing the 25 largest of 286 asset managers. See all 286 in the interactive database.

2. To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew Gline

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD 26%

FOR: 430,013,727WITHHELD: 154,432,135

Roivant Sciences Ltd.’s own tally for this item (“Elect Director: Matthew Gline”): 430,013,727 for, 154,432,135 withheld, per its Form 8-K filed 2025-09-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 682,229,832 outstanding shares: 63% for, 23% withheld (86% of the company cast a for/withheld vote).

The 70 asset managers below cast 100% of the shares they voted on this item FOR (93,276,845 for, 0 against).

FOR 72%ABSTAIN 28%

FOR: 93,276,845 (72.3%)ABSTAIN: 35,773,132 (27.7%)

Largest asset managers voting on “To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew G” at Roivant Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	38,008,316	8	For
Fidelity	6,394,753	27,552,227	Abstain
BlackRock	17,505,672	0	For
Morgan Stanley	8,789,842	7,964	For
State Street	4,990,116	0	For
Charles Schwab	2,865,389	0	For
TIAA	2,217,521	0	For
Transamerica	2,078,277	0	For
IMPAX FUNDS SERIES TRUST I	2,000,000	0	For
WisdomTree	0	1,767,115	Abstain
Goldman Sachs	1,660,066	0	For
Dimensional	0	1,562,980	Abstain
Equitable	1,526,704	0	For
TIFF INVESTMENT PROGRAM	1,403,699	0	For
T. Rowe Price	1,047,664	0	For
Brighthouse	575,835	332,056	For
Jackson National	0	782,901	Abstain
AIG/SunAmerica	0	477,034	Abstain
John Hancock	18,400	404,333	Abstain
Direxion Shares ETF Trust	0	395,758	Abstain
Columbia Threadneedle	376,695	0	For
Delaware/Macquarie	0	338,181	Abstain
JPMorgan	294,292	0	For
Northern Trust	288,515	0	For
BNY Mellon	0	266,779	Abstain

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

3. To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith Manchester

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD 29%

FOR: 412,869,513WITHHELD: 171,576,349

Roivant Sciences Ltd.’s own tally for this item (“Elect Director: Keith Manchester”): 412,869,513 for, 171,576,349 withheld, per its Form 8-K filed 2025-09-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 682,229,832 outstanding shares: 61% for, 25% withheld (86% of the company cast a for/withheld vote).

The 70 asset managers below cast 100% of the shares they voted on this item FOR (87,230,772 for, 0 against).

FOR 68%ABSTAIN 32%

FOR: 87,230,772 (67.6%)ABSTAIN: 41,819,205 (32.4%)

Largest asset managers voting on “To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith Man” at Roivant Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	38,008,315	9	For
Fidelity	6,394,753	27,552,227	Abstain
BlackRock	17,505,672	0	For
Morgan Stanley	8,789,842	7,964	For
State Street	0	4,990,116	Abstain
Charles Schwab	2,865,389	0	For
TIAA	2,217,521	0	For
Transamerica	2,078,277	0	For
IMPAX FUNDS SERIES TRUST I	2,000,000	0	For
WisdomTree	0	1,767,115	Abstain
Goldman Sachs	1,660,066	0	For
Dimensional	0	1,562,980	Abstain
Equitable	1,095,062	431,642	For
TIFF INVESTMENT PROGRAM	1,403,699	0	For
T. Rowe Price	1,047,664	0	For
Brighthouse	575,835	332,056	For
Jackson National	0	782,901	Abstain
AIG/SunAmerica	0	477,034	Abstain
John Hancock	18,400	404,333	Abstain
Direxion Shares ETF Trust	0	395,758	Abstain
Columbia Threadneedle	376,695	0	For
Delaware/Macquarie	0	338,181	Abstain
JPMorgan	294,292	0	For
Northern Trust	0	288,515	Abstain
BNY Mellon	0	266,779	Abstain

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

4. To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa Epperly

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%WITHHELD 27%

FOR: 429,542,705WITHHELD: 154,903,157

Roivant Sciences Ltd.’s own tally for this item (“Elect Director: Melissa Epperly”): 429,542,705 for, 154,903,157 withheld, per its Form 8-K filed 2025-09-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 682,229,832 outstanding shares: 63% for, 23% withheld (86% of the company cast a for/withheld vote).

The 70 asset managers below cast 100% of the shares they voted on this item FOR (92,845,203 for, 0 against).

FOR 72%ABSTAIN 28%

FOR: 92,845,203 (71.9%)ABSTAIN: 36,204,774 (28.1%)

Largest asset managers voting on “To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa E” at Roivant Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	38,008,316	8	For
Fidelity	6,394,753	27,552,227	Abstain
BlackRock	17,505,672	0	For
Morgan Stanley	8,789,842	7,964	For
State Street	4,990,116	0	For
Charles Schwab	2,865,389	0	For
TIAA	2,217,521	0	For
Transamerica	2,078,277	0	For
IMPAX FUNDS SERIES TRUST I	2,000,000	0	For
WisdomTree	0	1,767,115	Abstain
Goldman Sachs	1,660,066	0	For
Dimensional	0	1,562,980	Abstain
Equitable	1,095,062	431,642	For
TIFF INVESTMENT PROGRAM	1,403,699	0	For
T. Rowe Price	1,047,664	0	For
Brighthouse	575,835	332,056	For
Jackson National	0	782,901	Abstain
AIG/SunAmerica	0	477,034	Abstain
John Hancock	18,400	404,333	Abstain
Direxion Shares ETF Trust	0	395,758	Abstain
Columbia Threadneedle	376,695	0	For
Delaware/Macquarie	0	338,181	Abstain
JPMorgan	294,292	0	For
Northern Trust	288,515	0	For
BNY Mellon	0	266,779	Abstain

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

5. To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2026, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2026, and to authorize the Board of Direct

AUDIT-RELATED

100% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 100% of the shares they voted on this item FOR (128,452,744 for, 0 against).

FOR: 128,452,744 (99.9%)ABSTAIN: 84,082 (0.1%)

Largest asset managers voting on “To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's ind” at Roivant Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	38,008,324	0	For
Fidelity	33,946,980	0	For
BlackRock	17,505,672	0	For
Morgan Stanley	8,797,806	0	For
State Street	4,990,116	0	For
Charles Schwab	2,865,389	0	For
TIAA	2,217,521	0	For
Transamerica	2,078,277	0	For
IMPAX FUNDS SERIES TRUST I	2,000,000	0	For
WisdomTree	1,767,115	0	For
Goldman Sachs	1,660,066	0	For
Dimensional	1,562,980	0	For
Equitable	1,526,704	0	For
TIFF INVESTMENT PROGRAM	1,403,699	0	For
T. Rowe Price	1,047,664	0	For
Brighthouse	827,476	80,415	For
Jackson National	782,901	0	For
AIG/SunAmerica	477,034	0	For
John Hancock	422,733	0	For
Direxion Shares ETF Trust	395,758	0	For
Columbia Threadneedle	376,695	0	For
Delaware/Macquarie	338,181	0	For
Northern Trust	288,515	0	For
BNY Mellon	266,779	0	For
Bridge Builder Trust	252,013	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

0% fund support · no official result

ABSTAIN 99.1%

The 6 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 510,228 against).

AGAINST: 510,228 (0.9%)ABSTAIN: 59,036,571 (99.1%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Roivant Sciences Ltd., 2025-2026
Asset manager	Against	Abstain	Vote
SB INVESTMENT ADVISERS (UK) LTD	0	59,036,571	Abstain
JPMorgan	294,292	0	Against
Empower	191,791	0	Against
Lincoln Financial	12,136	0	Against
NORTHERN LIGHTS FUND TRUST II	12,000	0	Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	9	0	Against

7. Approve Ernst & Young LLP as Auditors and Authorize Board to Fix Their Remuneration

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (510,219 for, 0 against).

FOR: 510,219 (100.0%)

Largest asset managers voting on “Approve Ernst & Young LLP as Auditors and Authorize Board to Fix Their Remuneration” at Roivant Sciences Ltd., 2025-2026
Asset manager	For	Vote
JPMorgan	294,292	For
Empower	191,791	For
Lincoln Financial	12,136	For
NORTHERN LIGHTS FUND TRUST II	12,000	For

8. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (2,208,993 for, 0 against).

FOR: 2,208,993 (100.0%)

Largest asset managers voting on “14A Executive Compensation” at Roivant Sciences Ltd., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
DME Capital Management, LP	2,208,920	0	0	0	For
Cove Private Wealth, LLC	73	0	0	0	For

Largest Roivant Sciences Ltd. shareholders voting in 2025-2026

Ranked by the number of Roivant Sciences Ltd. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 682,229,832 shares outstanding at the time of that meeting.

Top Roivant Sciences Ltd. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Fidelity	12.77%
2	Vanguard	5.76%
3	Morgan Stanley	5.36%
4	VIKING GLOBAL INVESTORS LP	4.44%
5	BlackRock	4.39%
6	QVT Financial LP	4.31%
7	State Street	1.91%
8	GEODE CAPITAL MANAGEMENT, LLC	1.09%
9	Two Seas Capital LP	0.86%
10	Charles Schwab	0.85%

Reported Roivant Sciences Ltd. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Roivant Sciences Ltd. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Dexxon Holdings	15.08%	DEF14A
FMR (Fidelity)	11.43%	13F
FMR LLC	10.79%	DEF14A
BlackRock	6.49%	13F
Vanguard Group	6.16%	13F
Morgan Stanley	5.96%	13G
Ramaswamy Vivek	3.74%	13G
Mayukh Sukhatme President and Chief Investment Officer and Director	2.95%	DEF14A
Matthew Gline Chief Executive Officer and Director	2.75%	DEF14A
SB Investment Advisers (UK) Limited	2.41%	13G

Percentages above are of 682,229,832 shares outstanding, as reported by Roivant Sciences Ltd. on its Form 10-Q dated 2025-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Roivant Sciences Ltd.’s 10-Q dated 2025-06-30. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Roivant Sciences Ltd.'s shareholder meeting held 2025-09-10, in the 2025-2026 proxy season, 296 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,795 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Roivant Sciences Ltd.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To cast a non-binding, advisory vote to approve the compensation of our named executive… — the reporting funds cast 36% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Roivant Sciences Ltd. proxy season coverage: 2024-2025 · 2025-2026 (this page).